Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-20-058075

Chief Financial Officer sold 43,505 shares at an average $69.37 ($3,018,071)

  • Chief Financial Officer acquired 43,505 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Myszkowski Kenneth Allen Chief Financial Officer 2020-11-09 Option exercise +43,505 $14.54 $632,563 471,173 D
Myszkowski Kenneth Allen Chief Financial Officer 2020-11-09 Sale −25,840 $69.04 $1,783,994 445,333 D
Myszkowski Kenneth Allen Chief Financial Officer 2020-11-09 Sale −17,665 $69.86 $1,234,077 427,668 D
Derivatives
Myszkowski Kenneth Allen Chief Financial Officer 2020-11-09 Option exercise · Stock Option (right to buy) −43,505 0 D
Open-market sales · 43,505 sh · avg $69.37 · $3,018,071
Loading xslF345X03/doc4.xml…